Impact of pharmacotherapy on interstage mortality and weight gain in children with single ventricle

Congenital Heart Disease

Volumn 8, Issue 3, 2013, Pages 219-227

  Ghelani, Sunil J ^a,b   Spurney, Christopher F ^a   Martin, Gerard R ^a   Cross, Russell R ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Pharmacotherapy; Quality Improvement; Single Ventricle

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; CAPTOPRIL; CHLOROTHIAZIDE; CLONIDINE; CLOPIDOGREL; DIGOXIN; ENALAPRIL; ERYTHROMYCIN; FUROSEMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; LANSOPRAZOLE; LISINOPRIL; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; METHADONE; METOCLOPRAMIDE; MULTIVITAMIN; OMEPRAZOLE; PROPRANOLOL; SILDENAFIL; SOTALOL; SPIRONOLACTONE;

ARTICLE; BODY GROWTH; CHILD; FEMALE; HEART SINGLE VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWOOD PROCEDURE; PALLIATIVE THERAPY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WEIGHT GAIN;

BIRTH WEIGHT; CARDIOVASCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; WEIGHT GAIN;

EID: 84878681581     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/chd.12020     Document Type: Article

References (39)

1. Karamlou T, Diggs BS, Ungerleider RM, Welke KF. Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period. J Thorac Cardiovasc Surg. 2010;139:119-126. discussion 126-127.
2. Kelleher DK, Laussen P, Teixeira-Pinto A, Duggan C. Growth and correlates of nutritional status among infants with hypoplastic left heart syndrome (HLHS) after stage 1 Norwood procedure. Nutrition. 2006;22:237-244.
3. Davis D, Davis S, Cotman K, etal. Feeding difficulties and growth delay in children with hypoplastic left heart syndrome versus d-transposition of the great arteries. Pediatr Cardiol. 2008;29:328-333.
4. Lee JR, Choi JS, Kang CH, Bae EJ, Kim YJ, Rho JR. Surgical results of patients with a functional single ventricle. Eur J Cardiothorac Surg. 2003;24:716-722.
5. Hehir DA, Dominguez TE, Ballweg JA, etal. Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg. 2008;136:94-99, 99.e1-3.
6. Ghanayem NS, Hoffman GM, Mussatto KA, etal. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg. 2003;126:1367-1377.
7. Fenton KN, Siewers RD, Rebovich B, Pigula FA. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg. 2003;76:152-156; discussion 156-157.
8. Azakie A, Martinez D, Sapru A, Fineman J, Teitel D, Karl TR. Impact of right ventricle to pulmonary artery conduit on outcome of the modified Norwood procedure. Ann Thorac Surg. 2004;77:1727-1733.
9. Mahle WT, Spray TL, Gaynor JW, Clark BJ 3rd. Unexpected death after reconstructive surgery for hypoplastic left heart syndrome. Ann Thorac Surg. 2001;71:61-65.
10. Simsic JM, Bradley SM, Stroud MR, Atz AM. Risk factors for interstage death after the Norwood procedure. Pediatr Cardiol. 2005;26:400-403.
11. De Oliveira NC, Ashburn DA, Khalid F, etal. Prevention of early sudden circulatory collapse after the Norwood operation. Circulation. 2004;110:II133-II138.
12. Gaynor JW, Mahle WT, Cohen MI, etal. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg. 2002;22:82-89.
13. Pizarro C, Mroczek T, Malec E, Norwood WI. Right ventricle to pulmonary artery conduit reduces interim mortality after stage 1 Norwood for hypoplastic left heart syndrome. Ann Thorac Surg. 2004;78:1959-1963; discussion 1963-1964.
14. Bartram U, Grünenfelder J, Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Ann Thorac Surg. 1997;64:1795-1802.
15. Wright GE, Crowley DC, Charpie JR, Ohye RG, Bove EL, Kulik TJ. High systemic vascular resistance and sudden cardiovascular collapse in recovering Norwood patients. Ann Thorac Surg. 2004;77:48-52.
16. Patel A, Hickey E, Mavroudis C, etal. Impact of noncardiac congenital and genetic abnormalities on outcomes in hypoplastic left heart syndrome. Ann Thorac Surg. 2010;89:1805-1813; discussion 1813-1814.
17. Vogt KN, Manlhiot C, Van Arsdell G, Russell JL, Mital S, McCrindle BW. Somatic growth in children with single ventricle physiology impact of physiologic state. J Am Coll Cardiol. 2007;50:1876-1883.
18. Anderson JB, Beekman RH 3rd, Border WL, etal. Lower weight-for-age z score adversely affects hospital length of stay after the bidirectional Glenn procedure in 100 infants with a single ventricle. J Thorac Cardiovasc Surg. 2009;138:397-404.
19. Golbus JR, Wojcik BM, Charpie JR, Hirsch JC. Feeding complications in hypoplastic left heart syndrome after the Norwood procedure: a systematic review of the literature. Pediatr Cardiol. 2011;32:539-552.
20. Garcia X, Jaquiss RDB, Imamura M, Swearingen CJ, Dassinger MS 3rd, Sachdeva R. Preemptive gastrostomy tube placement after Norwood operation. J Pediatr. 2011;159:602-607.e1.
21. Srinivasan C, Sachdeva R, Morrow WR, etal. Standardized management improves outcomes after the Norwood procedure. Congenit Heart Dis. 2009;4:329-337.
22. Hsu DT, Zak V, Mahony L, etal. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122:333-340.
23. Li JS, Yow E, Berezny KY, etal. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation. 2007;116:293-297.
24. Moffett BS, Mattamal R, Ocampo EC, Petit CJ. Impact of pharmacotherapy on interstage outcomes in single ventricle infants. Congenit Heart Dis. 2011;6:286-293.
25. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
26. Growth Charts-Z-score Data Files [Internet]. Available at: http://www.cdc.gov/growthcharts/zscore.htm. Accessed March 16, 2012.
27. Kantor PF, Redington AN. Pathophysiology and management of heart failure in repaired congenital heart disease. Heart Fail Clin. 2010;6:497-506.
28. Williams RV, Ravishankar C, Zak V, etal. Birth weight and prematurity in infants with single ventricle physiology: pediatric heart network infant single ventricle trial screened population. Congenit Heart Dis. 2010;5:96-103.
29. Anderson JB, Iyer SB, Schidlow DN, etal. Variation in Growth of Infants with a Single Ventricle. J Pediatr. [Internet]. 2012;161:16-21.e1 Available at: http://www.ncbi.nlm.nih.gov/pubmed/22336578. Accessed May 7, 2012.
30. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45:421-427.
31. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514-520.
32. Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic drug therapy in children: a review of current options. Ann Pharmacother. 2005;39:706-711.
33. Jeffries HE, Wells WJ, Starnes VA, Wetzel RC, Moromisato DY. Gastrointestinal morbidity after Norwood palliation for hypoplastic left heart syndrome. Ann Thorac Surg. 2006;81:982-987.
34. Winnick S, Lucas DO, Hartman AL, Toll D. How do you improve compliance? Pediatrics. 2005;115:e718-e724.
35. Nahata MC, Allen LV Jr. Extemporaneous drug formulations. Clin Ther. 2008;30:2112-2119.
36. Milne C-P, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther. 2008;30:2133-2145.
37. Brown DW, Connor JA, Pigula FA, etal. Variation in preoperative and intraoperative care for first-stage palliation of single-ventricle heart disease: a report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative. Congenit Heart Dis. 2011;6:108-115.
38. Baker-Smith CM, Neish SR, Klitzner TS, etal. Variation in postoperative care following stage I palliation for single-ventricle patients: a report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative. Congenit Heart Dis. 2011;6:116-127.
39. Schidlow DN, Anderson JB, Klitzner TS, etal. Variation in interstage outpatient care after the Norwood procedure: a report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative. Congenit Heart Dis. 2011;6:98-107.